LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
I asked ChatGPT for the best FTSE 100 stock! Here’s what it said…
Investing Articles
I asked ChatGPT for the best FTSE 100 stocks for a rotation out of tech! Here’s what it said
Investing Articles
Late to investing? Don’t worry… here’s how we aim to build a retirement-boosting ISA
Investing Articles
How much do you need in an ISA to target £1,799 in monthly passive income?
Investing Articles
Late to investing? Here are Dr James Fox’s favourite FTSE 100 stocks right now
Investing Articles
2 overlooked UK shares to consider for dividend income
Investing Articles
These undervalued FTSE 100 shares could rise more than 50% over the next year, according to brokers
Investing Articles
After crashing 50%+, is this a bargain-basement growth stock?
Investing Articles
A $236bn growth opportunity!? Is this FTSE 100 stock about to skyrocket?
Investing Articles
Could this ‘average’ FTSE 100 stock be one to consider in these difficult times?
Investing Articles
Is this FTSE 100 share a screaming buy to consider after recent falls?